Mutated FLT-3 proteins are involved in activating several signaling pathways, for example MAPK/ERK and STAT5, and thus indicate a higher risk of developing leukemia as well as a worse prognosis (Cheng et al., 2018). This evidence concerns the gene FLT3 and leukemia.